Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals

Stallmach, Andreas; Anttila, Veli Jukka; Hell, Markus; Gwynn, Simon; Merino-Amador, Paloma; Petrosillo, Nicola; Ráčil, Zdeněk; Warren, Tim; Wenisch, Christoph; Wilcox, Mark H.

doi:10.1055/s-0044-100045

Cited by 4 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with inflammatory bowel disease (IBD) retain an increased risk of developing CDI, along with worse outcomes, higher rates of colectomy, and higher rates of recurrence [110–115].…”

Section: Risk Factorsmentioning

confidence: 99%

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

et al. 2019

Self Cite

View full text Add to dashboard Cite

In the last three decades, Clostridium difficile infection (CDI) has increased in incidence and severity in many countries worldwide. The increase in CDI incidence has been particularly apparent among surgical patients. Therefore, prevention of CDI and optimization of management in the surgical patient are paramount. An international multidisciplinary panel of experts from the World Society of Emergency Surgery (WSES) updated its guidelines for management of CDI in surgical patients according to the most recent available literature. The update includes recent changes introduced in the management of this infection.

show abstract

Section: Risk Factorsmentioning

confidence: 99%

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Only a few are designed to analyze the methodology, clinical decision, safety and cost-efficacy of FMT. A multidisciplinary survey by a group of international clinicians (Stallmach et al, 2018 ) showed the different perceptions on the use of FMT in IBD patients. More questions on indications beyond CDI and IBD remain unanswered.…”

Section: Introductionmentioning

confidence: 99%

Microbiota transplantation: concept, methodology and strategy for its modernization

Zhang¹,

Cui²,

He³

et al. 2018

Protein Cell

215

192

View full text Add to dashboard Cite

Fecal microbiota transplantation (FMT) has become a research focus of biomedicine and clinical medicine in recent years. The clinical response from FMT for different diseases provided evidence for microbiota-host interactions associated with various disorders, including Clostridium difficile infection, inflammatory bowel disease, diabetes mellitus, cancer, liver cirrhosis, gut-brain disease and others. To discuss the experiences of using microbes to treat human diseases from ancient China to current era should be important in moving standardized FMT forward and achieving a better future. Here, we review the changing concept of microbiota transplantation from FMT to selective microbiota transplantation, methodology development of FMT and step-up FMT strategy based on literature and state experts’ perspectives.

show abstract

“…6 Isolated case series of CDI contributing to symptomatic relapse in IBD patients have been documented since then. [7][8][9] The most prevalent way of acquiring CDI is from environmental exposure. The most prevalent environment for CDI infection is hospitals, which raises the risk of nosocomial infection.…”

Section: Introductionmentioning

confidence: 99%

Clostridium Difficile Infection (CDI) Among Egyptian Patients with Inflammatory Bowel Disease

ezzat

2022

Al-Azhar International Medical Journal

View full text Add to dashboard Cite

Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals

Abstract: Different perceptions both between specialties and geographical locations complicate the development of an internationally accepted algorithm for the diagnosis and treatment of CDI in patients with IBD. This study highlights the need for future studies in this area.

Cited by 4 publications

References 46 publications

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

Microbiota transplantation: concept, methodology and strategy for its modernization

Clostridium Difficile Infection (CDI) Among Egyptian Patients with Inflammatory Bowel Disease

Contact Info

Product

Resources

About